Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Peptide Synthesis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113135991A reveals a fragment condensation method reducing D-His impurities. Enhances purity and yield for scalable GLP-1 manufacturing.
Novel thalidomide-based PROTACs for fibrosis and cancer. Efficient solid-phase synthesis ensures high purity and scalable supply chain solutions.
Patent CN101838308A reveals a streamlined solid-phase route for Eptifibatide using single-protected amino acids and rapid hydrogen peroxide oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Novel solid-phase method enhances purity and yield. Reliable supply chain for complex peptide intermediates with optimized cyclization.
Advanced solid-phase method improves purity and yield for bremelanotide manufacturing, offering cost reduction and supply chain stability for global partners.
Advanced Fmoc solid-phase synthesis for Triptorelin bulk drug. Patent CN103012565A offers high yield, low racemization, and scalable manufacturing for reliable supply chains.
Patent CN102190709A details a novel two-fragment solid-phase synthesis for LH-RH derivatives, offering high purity and cost-effective manufacturing solutions.
Patent CN103087177A details microwave-assisted solid-phase synthesis of stable GLP-1 analogues with extended half-life, offering cost-effective manufacturing solutions.
Novel patent CN119823209A enables high-purity cyclic peptide production with reduced side reactions and improved supply chain reliability for pharmaceutical intermediates.
Novel solid-phase synthesis of Teixobactin analogs via copper-mediated cyclization. Reduces steps and cost for antibiotic manufacturing.
Novel solid-phase synthesis method for Apraglutide improves yield and purity. Reduces hydrophobic aggregation issues for reliable pharmaceutical intermediate supply.
Patent CN116425824A reveals a novel solid-phase method for S-2732 synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN104371010B details a safer Fmoc solid-phase synthesis for Ganirelix. This method improves yield and purity while eliminating toxic HF usage for reliable supply.
Patent CN102775471B details a hybrid synthesis for Cholecystokinin Octapeptide. This method offers high purity, avoids hazardous HF, and ensures scalable API intermediate production.
Patent CN101357937A details an efficient Fmoc-based SPPS route for Atosiban, offering high purity and reduced waste for pharmaceutical manufacturing.
Advanced preparation of Desmopressin Acetate via solid-phase synthesis and liquid-phase oxidation. High purity, scalable process for reliable pharmaceutical intermediates supply.
Novel cyclic peptide patent CN109897091A offers high stability against Candida albicans. Reliable supplier for scalable pharmaceutical intermediate manufacturing.
Patent CN104628826A details a high-yield Linaclotide method. This report analyzes supply chain benefits and cost reduction in API manufacturing for procurement teams.
Patent CN108484735A details solid-phase synthesis of cyclic heptapeptides. Offers high purity, scalable production, and cost-effective marine drug intermediate manufacturing solutions.
Patent CN103554226B details all-solid-phase synthesis for alpha-conotoxin MI. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing.